oxybutynin has been researched along with Blood Coagulation Disorders in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Blood Coagulation Disorders: Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cotechini, T | 1 |
| Othman, M | 1 |
| Graham, CH | 1 |
1 other study available for oxybutynin and Blood Coagulation Disorders
| Article | Year |
|---|---|
Nitroglycerin prevents coagulopathies and foetal death associated with abnormal maternal inflammation in rats.
Topics: Administration, Cutaneous; Animals; Blood Coagulation; Blood Coagulation Disorders; Etanercept; Fema | 2012 |